Deep knowledge on 
 small-molecule drugs and 
 the 110,000 global patents 
 covering them 

Free Patent Expiration Alerts


Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Vincristine sulfate - Generic Drug Details

« Back to Dashboard
Vincristine sulfate is the generic ingredient in six branded drugs marketed by Fresenius Kabi Usa, Lilly, Abraxis Pharm, Teva Parenteral, Hospira, Bristol Myers Squibb, Abic, Teva Pharms Usa, and Talon Therap, and is included in thirteen NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has forty-nine patent family members in sixteen countries.

There are thirteen drug master file entries for vincristine sulfate. Three suppliers are listed for this compound.

Summary for Generic Name: vincristine sulfate

Tradenames:6
Patents:3
Applicants:9
NDAs:13
Drug Master File Entries: see list13
Suppliers / Packaging: see list3
Formulation / Manufacturing:see details

Pharmacology for Ingredient: vincristine sulfate

Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid

Clinical Trials for: vincristine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
VINCRISTINE SULFATE PFS
vincristine sulfate
INJECTABLE;INJECTION075493-001Sep 1, 1999RXNo<disabled><disabled>
Fresenius Kabi Usa
VINCRISTINE SULFATE
vincristine sulfate
INJECTABLE;INJECTION076296-001Dec 20, 2002DISCNNo<disabled><disabled>
Bristol Myers Squibb
VINCREX
vincristine sulfate
INJECTABLE;INJECTION070867-001Jul 12, 1988DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: vincristine sulfate

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Talon Therap
MARQIBO KIT
vincristine sulfate
INJECTABLE, LIPOSOMAL;INTRAVENOUS202497-001Aug 9, 20125,741,516<disabled>
Talon Therap
MARQIBO KIT
vincristine sulfate
INJECTABLE, LIPOSOMAL;INTRAVENOUS202497-001Aug 9, 20125,814,335<disabled>
Talon Therap
MARQIBO KIT
vincristine sulfate
INJECTABLE, LIPOSOMAL;INTRAVENOUS202497-001Aug 9, 20125,543,152<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: vincristine sulfate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,452,550Liposomal antineoplastic drugs and uses thereof<disabled in preview>
7,244,450Compositions and methods for treating lymphoma<disabled in preview>
7,060,828Liposomal camptothecins and uses thereof<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: vincristine sulfate

Country Document Number Estimated Expiration
Australia7785301<disabled in preview>
European Patent Office1299084<disabled in preview>
Japan2014088444<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Connect with Social Media:

`abc